1. Homepage
  2. Equities
  3. Germany
  4. Xetra
  5. Gerresheimer AG
  6. Summary
    GXI   DE000A0LD6E6

GERRESHEIMER AG

(GXI)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Xetra
05/19/2022 05/20/2022 05/23/2022 05/24/2022 05/25/2022 Date
65.5(c) 67.45(c) 67.95(c) 68.45(c) 67.75 Last
52 825 65 274 34 051 72 878 4 503 Volume
-0.08% +2.98% +0.74% +0.74% -1.02% Change
More quotes
Estimated financial data (e)
Sales 2022 1 687 M 1 810 M 1 810 M
Net income 2022 117 M 126 M 126 M
Net Debt 2022 1 050 M 1 127 M 1 127 M
P/E ratio 2022 18,6x
Yield 2022 1,94%
Sales 2023 1 800 M 1 931 M 1 931 M
Net income 2023 150 M 161 M 161 M
Net Debt 2023 1 014 M 1 088 M 1 088 M
P/E ratio 2023 14,6x
Yield 2023 2,26%
Capitalization 2 149 M 2 306 M 2 306 M
EV / Sales 2022 1,90x
EV / Sales 2023 1,76x
Nbr of Employees 10 625
Free-Float 100%
More Financials
Company
Gerresheimer AG is a Germany-based company that is active in the pharmaceuticals and health care industry. It operates through two business segments: Plastics and Devices, and Primary Packaging Glass. The Plastics and Devices segment produces standard and customized products for drug delivery, such as insulin pens, inhalers, and prefillable syrings. The Primary Packaging Glass segment focuses on the production of... 
More about the company
Ratings of Gerresheimer AG
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
A-
More Ratings
All news about GERRESHEIMER AG
03:02aGERRESHEIMER AG : JP Morgan reiterates its Neutral rating
MD
05/16Gerresheimer AG Executes on Its Growth Strategy in Emerging Markets Boosting Capacities..
CI
05/16GERRESHEIMER AG : Gerresheimer executes on its growth strategy in Emerging Markets boostin..
EQ
05/11GERRESHEIMER AG : Berenberg reaffirms its Buy rating
MD
05/09Gerresheimer and Portal Enter Strategic Partnership to Treat Chronically Ill Patients w..
CI
05/09GERRESHEIMER AG : Gerresheimer and Portal enter strategic partnership to treat chronically..
EQ
04/13GERRESHEIMER AG : Credit Suisse reiterates its Buy rating
MD
04/12GERRESHEIMER AG : JP Morgan gives a Neutral rating
MD
04/11GERRESHEIMER AG : Gets a Buy rating from Deutsche Bank
MD
04/08GERRESHEIMER AG : Deutsche Bank keeps its Buy rating
MD
04/07GLOBAL MARKETS LIVE : Airbus, Berkshire Hathaway, Meta, Samsung, Tesla...
04/07TRANSCRIPT : Gerresheimer AG, Q1 2022 Earnings Call, Apr 07, 2022
CI
04/07GERRESHEIMER AG : JP Morgan reiterates its Neutral rating
MD
04/07GERRESHEIMER AG : Buy rating from Goldman Sachs
MD
04/07GERRESHEIMER : Presentation 1st Quarter 2022
PU
More news
News in other languages on GERRESHEIMER AG
05/20GERRESHEIMER : Lebensläufe Aufsichtsratskandidaten
05/16Gerresheimer AG poursuit sa stratégie de croissance sur les marchés émergents en renfor..
05/16Gerresheimer AG / Gerresheimer setzt seine Wachstumsstrategie in den ...
05/16GERRESHEIMER AG : Gerresheimer setzt seine Wachstumsstrategie in den Emerging Markets um u..
05/16GERRESHEIMER AG : Gerresheimer setzt seine Wachstumsstrategie in den Emerging Markets um u..
More news
Analyst Recommendations on GERRESHEIMER AG
More recommendations
Chart GERRESHEIMER AG
Duration : Period :
Gerresheimer AG Technical Analysis Chart | GXI | DE000A0LD6E6 | MarketScreener
Technical analysis trends GERRESHEIMER AG
Short TermMid-TermLong Term
TrendsBearishNeutralBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 8
Last Close Price 68,45 €
Average target price 92,11 €
Spread / Average Target 34,6%
EPS Revisions
Managers and Directors
Dietmar Siemssen Chief Executive Officer
Bernd Metzner Chief Financial Officer
Axel Herberg Chairman-Supervisory Board
Theodor Stuth Member-Supervisory Board
Udo Johannes Vetter Member-Supervisory Board
Sector and Competitors
1st jan.Capi. (M$)
GERRESHEIMER AG-19.19%2 306
ABBOTT LABORATORIES-19.16%201 411
MEDTRONIC PLC2.07%139 869
BECTON, DICKINSON AND COMPANY4.75%73 262
HOYA CORPORATION-21.65%38 307
BAXTER INTERNATIONAL INC.-13.91%36 944